Daniel H. Kim, M.D.
Radiation Oncologist
4.9 (58 RATINGS)
Appointments
Assistant Clinical Professor, Department of Radiation Oncology
Clinical Teams
Daniel H. Kim, M.D., is an assistant clinical professor and radiation oncologist in the Department of Radiation Oncology at City of Hope Arcadia.
Dr. Kim earned his medical degree from the University of California San Francisco (UCSF) School of Medicine, where he graduated with Alpha Omega Alpha honors, followed by an internship in internal medicine at the California Pacific Medical Center in San Francisco. He then joined City of Hope in 2010 as a resident in radiation oncology. In 2013, he was named chief resident, a position he held until joining our faculty full-time at City of Hope | Arcadia.
An active member of the medical community, Dr. Kim served as an advisory board member for the UCSF Academy of Medical Educators from 2006 to 2008. He also sat on a number of committees including the Association of Residents in Radiation Oncology - Website/Social Media Subcommittee and the City of Hope Graduate Medical Education Committee. Dr. Kim has multiple first-author publications in peer-reviewed journals, and has been awarded numerous fellowships, including the UCSF Low-Beer Fellowship in Oncology, UCSF Curriculum Ambassador Fellowship and the UCSF Dean's Research Fellowship. Dr. Kim also serves in multiple leadership roles in local and national organizations, including the Los Angeles Radiological Society where he is a member of the Executive Management Committee and chair of the Continuing Education Committee, as well as the Korean American Society for Radiation Oncology where he is a member of the leadership team and treasurer.
Dr. Kim is an active member of the medical staff at the Methodist Hospital of Southern California in Arcadia. He has held multiple leadership positions at Methodist Hospital including the cancer liaison physician for the Cancer Committee and has successfully led the hospital through multiple reaccreditations through the Commission on Cancer. He currently serves as chair of the Methodist Hospital Tumor Board and is an active member of the Cancer Committee and Radiation Safety Committee.
2009, M.D., University of California San Francisco School of Medicine
2003, B.A., Molecular and Cellular Biology, emphasis in Biochemistry Graduated With Distinction (Honors) University of California Berkeley
2013-2014, Radiation Oncology Chief Resident, City of Hope, Duarte, CA
2010-2013, Radiation Oncology Resident, City of Hope, Duarte, CA
2009-2010, California Pacific Medical Center, San Francisco, CA
2014-present, Assistant Clinical Professor and Radiation Oncologist, City of Hope, Arcadia, CA
2013 Clinical Investigation Training Program Scholar
2009 Elected to Alpha Omega Alpha (Medical Honors Society)
2008 Low-Beer Fellowship in Oncology (UCSF)
2006 UCSF Curriculum Innovation Award
2006 UCSF Curriculum Ambassador Fellowship
2006 UCSF Dean’s Research Fellowship
2004 UC Berkeley Outstanding Teaching Award Nominee
- Shinde A, Yang D, Frankel P, Liu A, Han C, Del Vecchio B, Schultheiss T, Cheng J, Li R, Kim D, Radany E, Hui S, Somlo G, Rosenthal J, Stein A, Forman S, Wong JYC. Radiation Related Toxicities Using Organ Sparing Total Marrow Irradiation Transplant Conditioning Regimens. Int J Radiat Oncol Biol Phys 2019 Dec 1;105(5):1025-33
- Kim DH, Schultheiss TE, Radany EH, Badie B, Pezner RD. Clinical Outcomes of Patients Treated with a Second Course of Stereotactic Radiosurgery for Locally or Regionally Recurrent Brain Metastases after Prior Stereotactic Radiosurgery. J Neurooncol 2013 Oct;115(1):37-43.
- Kim DH, Wang-Chesebro A, Weinberg V, Pouliot J, Chen L-M, Speight J, Littell R, Hsu I-C. High- Dose Rate Brachytherapy Using Inverse Planning Simulated Annealing for Locoregionally Advanced Cervical Cancer: A Clinical Report with 2-Year Follow-Up. Int J Radiat Oncol Biol Phys 2009 Dec 1;75(5):1329-34.
- Kim DH, Crawford B, Ziegler J, Beattie MS. Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations. Familial Cancer 2009;8(2):153-8.
- Aitken SM, Kim DH, Kirsch JF. Escherichia coli cystathionine gamma-synthase does not obey ping-pong kinetics. Novel continuous assays for the elimination and substitution reactions. Biochemistry (2003) 30;42(38):11297-306.
- Kim DH, Schultheiss TE, Radany EH, Badie B, Pezner RD. Clinical Outcomes of Patients Treated with a Second Course of Stereotactic Radiosurgery for Locally or Regionally Recurrent Brain Metastases after Prior Stereotactic Radiosurgery. J Neurooncol 2013 June 28 [Epub ahead of print].;
- Kim DH, Wang-Chesebro A, Weinberg V, Pouliot J, Chen L-M, Speight J, Littell R, Hsu I-C. High-Dose Rate Brachytherapy Using Inverse Planning Simulated Annealing for Locoregionally Advanced Cervical Cancer: A Clinical Report with 2-Year Follow-Up. Int J Radiat Oncol Biol Phys 2009 Dec 1;75(5):1329-34.;
- Kim DH, Crawford B, Ziegler J, Beattie MS. Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations. Familial Cancer 2009;8(2):153-8.;
- Aitken SM, Kim DH, Kirsch JF. Escherichia coli cystathionine gamma-synthase does not obey ping-pong kinetics. Novel continuous assays for the elimination and substitution reactions. Biochemistry (2003) 30;42(38):11297-306.
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with 5 stars being the highest.
Ratings
5.0
Provider explain in way you understand
5.0
Provider listen carefully to you
5.0
Show respect for what you say
5.0
Spend enough time with you
4.9
Know important info medical history
4.8
Rate provider 0-10
4.7
Recommend this provider office
Reviews
12/06/21
Doctor was concerned and caring about my condition. - Verified patient